Cargando…
Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer
Cytokine-induced killer (CIK) cell therapy is a type of adoptive immunotherapy that due to its high proliferation rate and anti-tumor characteristics, is being investigated to treat various solid tumors. Since advanced colorectal cancer (CRC) has high mortality and poor survival rates, and the effic...
Autores principales: | Fayyaz, Farimah, Yazdanpanah, Niloufar, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962105/ https://www.ncbi.nlm.nih.gov/pubmed/35346234 http://dx.doi.org/10.1186/s12964-022-00836-0 |
Ejemplares similares
-
Chronic myeloid leukemia stem cells: targeting therapeutic implications
por: Mojtahedi, Hanieh, et al.
Publicado: (2021) -
Safety and efficacy of T-cell-redirecting bispecific antibodies for patients with multiple myeloma: a systematic review and meta-analysis
por: Noori, Maryam, et al.
Publicado: (2023) -
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2016) -
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
por: Mohamed, Kawthar, et al.
Publicado: (2021) -
Immune-based therapeutic approaches in COVID-19
por: Moeinafshar, Aysan, et al.
Publicado: (2022)